OpenMed-ZeroShot-NER-Pharma-Small-166M

Focused on **chemical mentions** in the BC5CDR domain, capturing pharmaceutical compounds and therapeutic agents in context with diseases.Enables **pharmacovigilance**, **adverse event mining**, and **chemical–disease relation pipelines** when paired with downstream relation extraction. OpenMed ZeroShot NER is an advanced, domain-adapted Named Entity Recognition (NER) model designed specifically for medical, biomedical, and clinical text mining. Leveraging state-of-the-art zero-shot learning, this model empowers researchers, clinicians, and data scientists to extract expert-level biomedical entities—such as diseases, chemicals, genes, species, and clinical findings—directly from unstructured text, without the need for task-specific retraining. Built on the robust GLiNER architecture and fine-tuned on curated biomedical corpora, OpenMed ZeroShot NER delivers high-precision entity recognition for critical healthcare and life sciences applications. Its zero-shot capability means you can flexibly define and extract any entity type relevant to your workflow, from standard biomedical categories to custom clinical concepts, supporting rapid adaptation to new research domains and regulatory requirements.

翻訳準備中のため原文を表示しています